drugset / Trial / NCT04688632
Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A double-blind study to characterize the effect of ampreloxetine on cardiac repolarization in healthy subjects.
Timeline
- Start
- 2021-01-18
- Primary completion
- 2021-03-13
- Completion
- 2021-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | — | Oral |
| Subject | ampreloxetine | Small molecule | — | — |